The scripts included correspond to the image processing of the study entitled: A combined approach using T2*-weighted dynamic 
suscepti-bility contrast MRI perfusion parameters and radiomics to differentiate between radionecrosis and glioma progression: a 
proof of concept study , currently (24/03/2025) under review.
 
